Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Suppan

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Memo|May 11, 2022
ESMO 2021-my top three abstracts in breast cancerChristoph Suppan
Memo|July 21, 2017
Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016Christoph Suppan, Marija Balic
Annals of Translational Medicine|December 14, 2020
It is time to prepare for D-CARE!Christoph Suppan, Marija Balic
Breast Care (Basel, Switzerland)|March 6, 2023
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast CancerChristoph Suppan, Marija Balic
Breast Care (Basel, Switzerland)|January 15, 2021
Biomarkers in Her2- Positive DiseaseEva Valentina Klocker, Christoph Suppan
Breast Care (Basel, Switzerland)|September 26, 2022
Expert Discussion: ASCO 2022Marija Balic, Kerstin Wimmer, Christoph Suppan, et al.
International Journal of Molecular Sciences|January 8, 2023
Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 ExpressionIva Brcic, Andrea Maria Kluba, Theresa Marie Godschachner, et al.
Antioxidants (Basel, Switzerland)|December 15, 2019
Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell PhenotypeAna Čipak Gašparović, Lidija Milković, Nadia Dandachi, et al.
Breast Care (Basel, Switzerland)|January 27, 2022
Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer PatientsChristoph Suppan, Daniel Steiner, Eva Valentina Klocker, et al.
BMC Cancer|December 31, 2015
Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapyChristoph Suppan, Vesna Bjelic-Radisic, Marlen La Garde, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Memo|May 11, 2022
ESMO 2021-my top three abstracts in breast cancerChristoph Suppan
Memo|July 21, 2017
Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016Christoph Suppan, Marija Balic
Annals of Translational Medicine|December 14, 2020
It is time to prepare for D-CARE!Christoph Suppan, Marija Balic
Breast Care (Basel, Switzerland)|March 6, 2023
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast CancerChristoph Suppan, Marija Balic
Breast Care (Basel, Switzerland)|January 15, 2021
Biomarkers in Her2- Positive DiseaseEva Valentina Klocker, Christoph Suppan
Breast Care (Basel, Switzerland)|September 26, 2022
Expert Discussion: ASCO 2022Marija Balic, Kerstin Wimmer, Christoph Suppan, et al.
International Journal of Molecular Sciences|January 8, 2023
Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 ExpressionIva Brcic, Andrea Maria Kluba, Theresa Marie Godschachner, et al.
Antioxidants (Basel, Switzerland)|December 15, 2019
Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell PhenotypeAna Čipak Gašparović, Lidija Milković, Nadia Dandachi, et al.
Breast Care (Basel, Switzerland)|January 27, 2022
Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer PatientsChristoph Suppan, Daniel Steiner, Eva Valentina Klocker, et al.
BMC Cancer|December 31, 2015
Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapyChristoph Suppan, Vesna Bjelic-Radisic, Marlen La Garde, et al.
Pageof 3